Journals / Anatolian Current Medical Journal / 2026 / Volume: 8 Issue: 4

Erectile dysfunction in men with axial spondyloarthritis: beyond inflammatory activity toward neuropathic pain and multidimensional disease burden

Altuğ Güner(Bursa şehir hastanesi)0000-0001-7220-0288
Sümeyye Tuna Güner(No. 31 Şevki Ağırgiden Family Health Center)0009-0002-5923-6416
Olgun Deniz(Bursa City Hospital)0000-0001-5025-6344
Alev Alp(ULUDAĞ ÜNİVERSİTESİ, TIP FAKÜLTESİ, TIP PR.)0000-0002-3904-5463
Lale Altan(BURSA ULUDAĞ ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-6453-8382
Pages
—
Publication Date
2026-07-16
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These findings underscore the clinical value of incorporating sexual health assessment into routine care as part of a more holistic and patient-centered approach to management.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: To investigate sexual dysfunction in male patients with axial spondyloarthritis and to identify clinical factors associated with erectile dysfunction (ED).
📊
Key Findings & Data:Methods: This cross-sectional observational study included 69 male patients with axial spondyloarthritis and 40 age-matched healthy male controls.
💡
Conclusion & Impact:These findings underscore the clinical value of incorporating sexual health assessment into routine care as part of a more holistic and patient-centered approach to management.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Axial spondyloarthritis · erectile dysfunction · quality of life

Abstract

Aims: To investigate sexual dysfunction in male patients with axial spondyloarthritis and to identify clinical factors associated with erectile dysfunction (ED). Methods: This cross-sectional observational study included 69 male patients with axial spondyloarthritis and 40 age-matched healthy male controls. Associations between ED and clinical factors, including disease activity, functional status, spinal mobility, neuropathic pain features and treatment modalities were evaluated. Results: ED was significantly more frequent and more severe in patients with axial spondyloarthritis than in healthy controls. Sexual desire was also significantly lower in the patient group. Among patients with axial spondyloarthritis, those with ED had poorer disease-specific quality of life, more prominent neuropathic pain features and greater spinal mobility limitation. Erectile function (EF) was negatively correlated with functional impairment, reduced spinal mobility and poorer quality of life. Although several variables were associated with ED in univariate analyses, none remained independently significant in the multivariable model, suggesting that ED may reflect the cumulative impact of multiple interrelated domains of disease burden rather than a single isolated factor. Conclusion: Sexual dysfunction appears to be a common and multifactorial problem in male patients with axial spondyloarthritis, reflecting the broader impact of functional limitation, pain-related features, and reduced quality of life rather than inflammatory activity alone. These findings underscore the clinical value of incorporating sexual health assessment into routine care as part of a more holistic and patient-centered approach to management.

🔖

Cite This Article

Güner, A., Güner, S. T., Dandinoğlu, T., Deniz, O., Alp, A., Altan, L. (2026). Erectile dysfunction in men with axial spondyloarthritis: beyond inflammatory activity toward neuropathic pain and multidimensional disease burden. Anatolian Current Medical Journal, Volume: 8 Issue: 4. https://doi.org/10.38053/acmj.1953569

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (27)

  1. Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017;390(10089): 73-84. doi:10.1016/S0140-6736(16)31591-4
  2. Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis International Society Classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777-783. doi:10.1136/ard.2009.108233
  3. Sepriano A, Ramiro S, van der Heijde D, et al. What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohorts. Ann Rheum Dis. 2020;79(3):324-331. doi:10.1136/annrheumdis-2019-216516
  4. Dougados M, Baeten D. Spondyloarthritis. Lancet. 2011;377(9783):2127-2137. doi:10.1016/S0140-6736(11)60071-8
  5. López-Medina C, Ramiro S, van der Heijde D, et al. Characteristics and burden of disease in patients with radiographic and non-radiographic axial spondyloarthritis: a comparison by systematic literature review and meta-analysis. RMD Open. 2019;5(2):e001108. doi:10.1136/rmdopen-2019-001108
  6. Healey EL, Haywood KL, Jordan KP, Garratt AM, Ryan S, Packham JC. Ankylosing spondylitis and its impact on sexual relationships. Rheumatology (Oxford). 2009;48(11):1378-1381. doi:10.1093/rheumatology/kep143
  7. Sariyildiz MA, Batmaz I, Dilek B, et al. Relationship of the sexual functions with the clinical parameters, radiological scores and the quality of life in male patients with ankylosing spondylitis. Rheumatol Int. 2013;33(3):623-629. doi:10.1007/s00296-012-2432-2
  8. Cakar E, Dincer U, Kiralp MZ, et al. Sexual problems in male ankylosing spondylitis patients: relationship with functionality, disease activity, quality of life, and emotional status. Clin Rheumatol. 2007;26(10):1607-1613. doi:10.1007/s10067-007-0545-x
  9. McCabe MP, Sharlip ID, Lewis R, et al. Incidence and prevalence of sexual dysfunction in women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015. J Sex Med. 2016;13(2):144-152. doi:10.1016/j.jsxm.2015.12.034
  10. Oaklander AL, Nolano M. Scientific advances in and clinical approaches to small-fiber polyneuropathy: a review. JAMA Neurol. 2019;76(10):1240-1251. doi:10.1001/jamaneurol.2019.2917
  11. Bennett MI, Attal N, Backonja MM, et al. Using screening tools to identify neuropathic pain. Pain. 2007;127(3):199-203. doi:10.1016/j.pain.2006.10.034
  12. Bennett M. The LANSS Pain Scale: the Leeds Assessment of Neuropathic Symptoms and Signs. Pain. 2001;92(1-2):147-157. doi:10.1016/s0304-3959(00)00482-6
  13. Bal S, Bal K, Turan Y, et al. Sexual functions in ankylosing spondylitis. Rheumatol Int. 2011;31(7):889-894. doi:10.1007/s00296-010-1406-5
  14. Dhakad U, Singh BP, Das SK, et al. Sexual dysfunctions and lower urinary tract symptoms in ankylosing spondylitis. Int J Rheum Dis. 2015;18(8):866-872. doi:10.1111/1756-185X.12683
  15. Dincer U, Cakar E, Kiralp MZ, Dursun H. Assessment of sexual dysfunction in male patients with ankylosing spondylitis. Rheumatol Int. 2007;27(6):561-566. doi:10.1007/s00296-006-0248-7
  16. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822-830. doi:10.1016/S0090-4295(97)00238-0
  17. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319-326. doi:10.1038/sj.ijir.3900472
  18. Turunç T, Deveci S, Güvel S, Peşkircioğlu L. The assessment of Turkish validation with 5 question version of International Index of Erectile Function (IIEF-5). Turk J Urol. 2007;33(1):45-49.
  19. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994; 21(12):2286-2291.
  20. Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N. A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int. 2005;25(4):280-284. doi:10.1007/s00296-003-0432-y
  21. Yanik B, Gürsel YK, Kutlay S, Ay S, Elhan AH. Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: functional assessment in AS. Clin Rheumatol. 2005;24(1):41-47. doi:10.1007/s10067-004-0968-6
  22. Jones SD, Porter J, Garrett SL, Kennedy LG, Whitelock H, Calin A. A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI). J Rheumatol. 1995;22(8):1609.
  23. Duruöz MT, Doward L, Turan Y, et al. Translation and validation of the Turkish version of the Ankylosing Spondylitis Quality of Life (ASQoL) questionnaire. Rheumatol Int. 2013;33(11):2717-2722. doi:10.1007/s00296-013-2796-y
  24. Yucel A, Senocak M, Kocasoy Orhan E, Cimen A, Ertas M. Results of the Leeds Assessment of Neuropathic Symptoms and Signs pain scale in Turkey: a validation study. J Pain. 2004;5(8):427-432. doi:10.1016/j.jpain.2004.07.001
  25. Pathan EMI, Inman RD. Pain in axial spondyloarthritis: insights from immunology and brain imaging. Rheum Dis Clin North Am. 2021;47(2): 197-213. doi:10.1016/j.rdc.2020.12.007
  26. Kebir H, Kreymborg K, Ifergan I, et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med. 2007;13(10):1173-1175. doi:10.1038/nm1651
  27. Kaltsonoudis E, Voulgari PV, Konitsiotis S, Drosos AA. Demyelination and other neurological adverse events after anti-TNF therapy. Autoimmun Rev. 2014;13(1):54-58. doi:10.1016/j.autrev.2013.09.002